CoChat

Combined JAK inhibition and PD-1 immunotherapy for non–small cell lung cancer patients

Open access
Mathew, Divij, Marmarelis, Melina E., Foley, Caitlin, Bauml, Joshua M., Ye, Darwin, Ghinnagow, Reem, Ngiow, Shin Foong, Klapholz, Max, Jun, Soyeong, Zhang, Zhaojun, Zorc, Robert, Davis, Christiana W., Diehn, Maximillian, Giles, Josephine R., Huang, Alexander C., Hwang, Wei-Ting, Zhang, Nancy R., Schoenfeld, Adam J., Carpenter, Erica L., Langer, Corey J., Wherry, E. John, Minn, Andy J. · 2024 · Science
Cited by 232

The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.

Abstract

Persistent inflammation driven by cytokines such as type-one interferon (IFN-I) can cause immunosuppression. We show that administration of the Janus kinase 1 (JAK1) inhibitor itacitinib after anti–PD-1 (programmed cell death protein 1) immunotherapy improves immune function and antitumor responses in mice and results in high response rates (67%) in a phase 2 clinical trial for metastatic non–small cell lung cancer. Patients who failed to respond to initial anti–PD-1 immunotherapy but responded after addition of itacitinib had multiple features of poor immune function to anti–PD-1 alone that improved after JAK inhibition. Itacitinib promoted CD8 T cell plasticity and therapeutic responses of exhausted and effector memory–like T cell clonotypes. Patients with persistent inflammation refractory to itacitinib showed progressive CD8 T cell terminal differentiation and progressive disease. Thus, JAK inhibition may improve the efficacy of anti–PD-1 immunotherapy by pivoting T cell differentiation dynamics.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1126/science.adf1329

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 232

Metadata

Authors
Mathew, D., Marmarelis, M. E., Foley, C., Bauml, J. M., Ye, D., Ghinnagow, R., Ngiow, S. F., Klapholz, M., Jun, S., Zhang, Z., Zorc, R., Davis, C. W., Diehn, M., Giles, J. R., Huang, A. C., Hwang, W.-T., Zhang, N. R., Schoenfeld, A. J., Carpenter, E. L., Langer, C. J., Wherry, E. J., & Minn, A. J.
Venue
Science
Published
2024-06-21
Volume
384
Issue
6702
Pages
eadf1329-eadf1329
ISSN
  • 0036-8075 (ISSN-L)
  • 1095-9203
OpenAlex
W4399848783
Cited by
232
References
19
FWCI
35.61
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.